Literature DB >> 16714586

MyD88-dependent signaling affects the development of meningococcal sepsis by nonlipooligosaccharide ligands.

Laura Plant1, Hong Wan, Ann-Beth Jonsson.   

Abstract

The Toll-like receptors (TLRs) and the adaptor myeloid differentiation factor 88 (MyD88) are important in the innate immune defenses of the host to microbial infections. Meningococcal ligands signaling via TLRs control inflammatory responses, and stimulation can result in fulminant meningococcal sepsis. In this study, we show that the responses to nonlipooligosaccharide (non-LOS) ligands of meningococci are MyD88 dependent. An isogenic LOS-deficient mutant of the serogroup C meningococcal strain FAM20 caused fatal disease in wild type C57BL/6 mice that was not observed in MyD88-/- mice. Fatality correlated with high proinflammatory cytokine and C5a levels in serum, high neutrophil numbers in blood, and increased bacteremia at 24 h postinfection in the wild-type mice. Infection with the parent strain FAM20 resulted in fatality in 100% of the wild-type mice and 50% of the MyD88-/- mice. We conclude that both LOS and another neisserial ligand cause meningococcal sepsis in an in vivo mouse model and confirm that meningococcal LOS can act via both the MyD88- dependent and -independent pathways, while the non-LOS meningococcal ligand(s) acts only via the MyD88-dependent pathway.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16714586      PMCID: PMC1479290          DOI: 10.1128/IAI.00128-06

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  47 in total

1.  IFN-gamma-inducible protein 10 (IP-10; CXCL10)-deficient mice reveal a role for IP-10 in effector T cell generation and trafficking.

Authors:  Jennifer H Dufour; Michelle Dziejman; Michael T Liu; Josephine H Leung; Thomas E Lane; Andrew D Luster
Journal:  J Immunol       Date:  2002-04-01       Impact factor: 5.422

2.  Changing carriage rate of Neisseria meningitidis among university students during the first week of term: cross sectional study.

Authors:  K R Neal; J S Nguyen-Van-Tam; N Jeffrey; R C Slack; R J Madeley; K Ait-Tahar; K Job; M C Wale; D A Ala'Aldeen
Journal:  BMJ       Date:  2000-03-25

3.  Dendritic cell activation and cytokine production induced by group B Neisseria meningitidis: interleukin-12 production depends on lipopolysaccharide expression in intact bacteria.

Authors:  G L Dixon; P J Newton; B M Chain; D Katz; S R Andersen; S Wong; P van der Ley; N Klein; R E Callard
Journal:  Infect Immun       Date:  2001-07       Impact factor: 3.441

4.  A lipopolysaccharide-deficient mutant of Neisseria meningitidis elicits attenuated cytokine release by human macrophages and signals via toll-like receptor (TLR) 2 but not via TLR4/MD2.

Authors:  A C Pridmore; D H Wyllie; F Abdillahi; L Steeghs; P van der Ley ; S K Dower; R C Read
Journal:  J Infect Dis       Date:  2000-11-10       Impact factor: 5.226

5.  Gram-negative bacteria induce proinflammatory cytokine production by monocytes in the absence of lipopolysaccharide (LPS).

Authors:  H Uronen; A J Williams; G Dixon; S R Andersen; P Van Der Ley; M Van Deuren; R E Callard; N Klein
Journal:  Clin Exp Immunol       Date:  2000-12       Impact factor: 4.330

6.  Identification of meningococcal LPS as a major monocyte activator in IL-10 depleted shock plasmas and CSF by blocking the CD14-TLR4 receptor complex.

Authors:  Anna Bjerre; Berit Brusletto; Reidun Øvstebø; Gun Britt Joø; Peter Kierulf; Petter Brandtzaeg
Journal:  J Endotoxin Res       Date:  2003

7.  The class A macrophage scavenger receptor is a major pattern recognition receptor for Neisseria meningitidis which is independent of lipopolysaccharide and not required for secretory responses.

Authors:  Leanne Peiser; Menno P J De Winther; Katherine Makepeace; Michael Hollinshead; Philip Coull; Joyce Plested; Tatsuhiko Kodama; E Richard Moxon; Siamon Gordon
Journal:  Infect Immun       Date:  2002-10       Impact factor: 3.441

8.  Lipooligosaccharide-deficient Neisseria meningitidis shows altered pilus-associated characteristics.

Authors:  Barbara Albiger; Linda Johansson; Ann-Beth Jonsson
Journal:  Infect Immun       Date:  2003-01       Impact factor: 3.441

9.  Toll-like receptor 2 participates in mediation of immune response in experimental pneumococcal meningitis.

Authors:  Uwe Koedel; Barbara Angele; Tobias Rupprecht; Hermann Wagner; Andreas Roggenkamp; Hans-Walter Pfister; Carsten J Kirschning
Journal:  J Immunol       Date:  2003-01-01       Impact factor: 5.422

10.  Lessons from an LPS-deficient Neisseria meningitidis mutant.

Authors:  Peter van der Ley; Liana Steeghs
Journal:  J Endotoxin Res       Date:  2003
View more
  11 in total

1.  Neisseria meningitidis capsular polysaccharides induce inflammatory responses via TLR2 and TLR4-MD-2.

Authors:  Susu M Zughaier
Journal:  J Leukoc Biol       Date:  2010-12-29       Impact factor: 4.962

2.  Important role for Toll-like receptor 9 in host defense against meningococcal sepsis.

Authors:  Hong Sjölinder; Trine H Mogensen; Mogens Kilian; Ann-Beth Jonsson; Søren R Paludan
Journal:  Infect Immun       Date:  2008-09-15       Impact factor: 3.441

3.  Initial delay in the immune response to Francisella tularensis is followed by hypercytokinemia characteristic of severe sepsis and correlating with upregulation and release of damage-associated molecular patterns.

Authors:  Chris A Mares; Sandra S Ojeda; Elizabeth G Morris; Qun Li; Judy M Teale
Journal:  Infect Immun       Date:  2008-04-14       Impact factor: 3.441

4.  MyD88 signaling is not essential for induction of antigen-specific B cell responses but is indispensable for protection against Streptococcus pneumoniae infection following oral vaccination with attenuated Salmonella expressing PspA antigen.

Authors:  Sung-Moo Park; Hyun-Jeong Ko; Doo-Hee Shim; Jin-Young Yang; Yong-Ho Park; Roy Curtiss; Mi-Na Kweon
Journal:  J Immunol       Date:  2008-11-01       Impact factor: 5.422

5.  Prophylactic and therapeutic treatment with a synthetic analogue of a parasitic worm product prevents experimental arthritis and inhibits IL-1β production via NRF2-mediated counter-regulation of the inflammasome.

Authors:  Justyna Rzepecka; Miguel A Pineda; Lamyaa Al-Riyami; David T Rodgers; Judith K Huggan; Felicity E Lumb; Abedawn I Khalaf; Paul J Meakin; Marlene Corbet; Michael L Ashford; Colin J Suckling; Margaret M Harnett; William Harnett
Journal:  J Autoimmun       Date:  2015-05-11       Impact factor: 7.094

6.  Complement C5a Receptor 1 Exacerbates the Pathophysiology of N. meningitidis Sepsis and Is a Potential Target for Disease Treatment.

Authors:  Johannes B Herrmann; Marcel Muenstermann; Lea Strobel; Alexandra Schubert-Unkmeir; Trent M Woodruff; Scott D Gray-Owen; Andreas Klos; Kay O Johswich
Journal:  mBio       Date:  2018-01-23       Impact factor: 7.867

7.  Synthetic immunomodulation with a CRISPR super-repressor in vivo.

Authors:  Ryan LeGraw; Jeremy J Velazquez; Farzaneh Moghadam; Nan Cher Yeo; Chenxi Xu; Jin Park; Alejandro Chavez; Mo R Ebrahimkhani; Samira Kiani
Journal:  Nat Cell Biol       Date:  2020-09-03       Impact factor: 28.824

Review 8.  Toll-like receptors in sepsis-associated cytokine storm and their endogenous negative regulators as future immunomodulatory targets.

Authors:  V Kumar
Journal:  Int Immunopharmacol       Date:  2020-10-12       Impact factor: 4.932

9.  The soluble tumor necrosis factor receptor 1 as a potential early diagnostic and prognostic markers in intensive care unit patients with severe infections.

Authors:  Marta Stelmasiak; MaŁgorzata Mikaszewska-Sokolewicz; Grzegorz NiewiŃski; Barbara-Joanna BaŁan; Robert SŁotwiŃski
Journal:  Cent Eur J Immunol       Date:  2020-07-27       Impact factor: 2.085

Review 10.  Experimental and natural infections in MyD88- and IRAK-4-deficient mice and humans.

Authors:  Horst von Bernuth; Capucine Picard; Anne Puel; Jean-Laurent Casanova
Journal:  Eur J Immunol       Date:  2012-12       Impact factor: 5.532

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.